fda glp-1 compounding enforcement news october 2025 Last month, the issued 25 warning letters to telehealth companies over what it called false or misleading claims about compounded medications September 8, 2025: FDA launches

Rapid weight loss and metabolic changes may temporarily affect sleep patterns

The batch of the ARPE-19 cells used in this study was validated using short tandem repeat (STR) analysis by Cobioer Biosciences (Nanjing, China)

Results Subjects characteristics A total of 50 subjects out of 58 were recruited and completed the study, with a response rate of 89.7%

Potential for longer healthspan: Because GLP-1 drugs can reduce risk factors for chronic diseases (like diabetes, heart disease, and possibly neurodegenerative diseases), they could help people stay healthier for longer as they age

The company used to offer subscriptions for convenience without any additional savings, but its since added a 10% price cut for subscribers, bringing an already low $60 price point down to just $54 monthly